Keywords: top, management, changes, curagen, due, firm, corp

Top management changes at CuraGen

Article | 23 May 2005

Due to US firm CuraGen Corp's majority-owned subsidiary 454 Life Sciences partnership with Roche, the former's founder and chief executive, Jonathan ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in